Sildenafil Citrate (Viagra) Enhances Vasodilatation by Atrial Natriuretic Peptide in Normal Dogs

概要

論文の詳細を見る
Background Sildenafil citrate (Viagra) is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5, which might enhance the vasorelaxant and natriuretic actions of atrial natriuretic peptide (ANP) in patients with heart failure. The objective of this study was to examine the combined effect of Viagra on hemodynamic changes during infusion of exogenous ANP. Methods and Results Healthy male beagles were used to assess systemic blood pressure, pulmonary artery pressure (PAP), and plasma levels of cGMP. After hemodynamic variables were measured, 0.1μg・kg^<-1>・min^<-1> of ANP was given during this study. One hour after initiating infusion of ANP, 2mg/kg of sildenafil citrate or vehicle was given orally via a nasogastric tube. Hemodynamic changes were measured before and 1h after these administrations. Mean systemic and PAP decreased during infusion of ANP, and further decreased after sildenafil citrate administration, however, mean systemic blood pressure decreased within 10mmHg. Plasma levels of cGMP also increased after sildenafil citrate administration. Conclusion In normal dogs, sildenafil citrate enhances the vasodilator effect of ANP by increasing the cGMP level, however, the concomitant use of sildenafil citrate with ANP will not induce severe hypotension.
社団法人日本循環器学会の論文
2007-11-20